Sonendo, Inc. (NYSE:SONX – Get Rating) Director Vamsi Mohan Raj Pudipeddi acquired 50,000 shares of the business’s stock in a transaction on Tuesday, March 14th. The shares were purchased at an average price of $1.60 per share, with a total value of $80,000.00. Following the transaction, the director now owns 199,182 shares in the company, valued at approximately $318,691.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Sonendo Stock Up 11.9 %
NYSE:SONX opened at $1.98 on Friday. The company has a quick ratio of 6.32, a current ratio of 7.24 and a debt-to-equity ratio of 0.45. Sonendo, Inc. has a fifty-two week low of $0.86 and a fifty-two week high of $6.84. The firm’s fifty day simple moving average is $2.37 and its 200-day simple moving average is $1.94.
Analyst Upgrades and Downgrades
A number of brokerages have commented on SONX. The Goldman Sachs Group cut their price objective on shares of Sonendo from $2.50 to $2.25 and set a “buy” rating for the company in a research report on Monday, March 13th. Morgan Stanley cut their price objective on shares of Sonendo from $5.75 to $5.50 and set an “equal weight” rating for the company in a research report on Thursday, March 9th.
Hedge Funds Weigh In On Sonendo
Sonendo, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure.
- Get a free copy of the StockNews.com research report on Sonendo (SONX)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Sonendo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonendo and related companies with MarketBeat.com's FREE daily email newsletter.